Quick Answer
SUTRO BIOPHARMA, INC. reported Stockholders Equity of -$132.45 million for fiscal year 2025.
SUTRO BIOPHARMA, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$132.45M | -397.0% |
| 2024 | $44.60M | -70.2% |
| 2023 | $149.65M | -31.1% |
| 2022 | $217.05M | -14.1% |
| 2021 | $252.56M | -23.9% |
| 2020 | $332.05M | +239.6% |
| 2019 | $97.79M | -25.7% |
| 2018 | $131.54M | +220.7% |
| 2017 | -$109.00M | -19.9% |
| 2016 | -$90.90M | +3.2% |
| 2015 | -$93.90M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$87.27M | -178.5% | -171.8% |
| June 30, 2025 | -$32.11M | -121.1% | -24.4% |
| March 31, 2025 | -$25.81M | -126.3% | -157.9% |
| December 31, 2024 | $44.60M | -70.2% | -59.9% |
| September 30, 2024 | $111.22M | -1.1% | -26.9% |
| June 30, 2024 | $152.18M | -1.6% | +55.2% |
| March 31, 2024 | $98.02M | -47.1% | -34.5% |
| December 31, 2023 | $149.65M | -31.1% | +33.1% |
- SUTRO BIOPHARMA, INC. showed a decrease of -397.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2015–2025 period, SUTRO BIOPHARMA, INC.’s stockholders equity has declined by 41.1% (from -$93.90 million to -$132.45 million).
- The most recent figure is from SUTRO BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: